Jaguar Health, Inc.
JAGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7 | $1 | $0 | $0 |
| - Cash | $8 | $6 | $5 | $17 |
| + Debt | $37 | $37 | $35 | $29 |
| Enterprise Value | $36 | $32 | $29 | $13 |
| Revenue | $12 | $10 | $12 | $4 |
| % Growth | 19.8% | -18.4% | 175.8% | – |
| Gross Profit | $10 | $8 | $10 | $2 |
| % Margin | 83.3% | 79.1% | 83.1% | 46.2% |
| EBITDA | -$37 | -$33 | -$33 | -$42 |
| % Margin | -313.6% | -335.6% | -279.2% | -977.3% |
| Net Income | -$38 | -$41 | -$47 | -$53 |
| % Margin | -329.3% | -423.1% | -396.9% | -1,213.3% |
| EPS Diluted | -130.69 | -2,685 | -4,070,250 | -11,370,375 |
| % Growth | 95.1% | 99.9% | 64.2% | – |
| Operating Cash Flow | -$29 | -$33 | -$33 | -$35 |
| Capital Expenditures | -$0 | $0 | -$2 | -$0 |
| Free Cash Flow | -$30 | -$33 | -$35 | -$35 |